Baseline and Follow-up Candida Culture and Follow-up Symptomatic VVC by Treatment Group
| Baseline Candida Culture | Follow-Up Candida Culture | Follow-Up Symptomatic VVC | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Positive (n [%]) | Negative (n [%]) | Missing (n) | Positive (n [%]) | Negative (n [%]) | Missing (n) | Positive (n [%]) | Negative (n [%]) | Missing (n) | |
| Antibiotic group | 8 (18.2) | 36 (81.8) | 0 | 10 (37.0) | 17 (63.0) | 17 | 6 (22.2) | 21 (77.8)† | 17 |
| Control group | 6 (17.1) | 29 (82.9) | 1 | 3 (11.1) | 24 (88.9) | 9 | 0 (0) | 26 (100) | 10 |
| RR* (95% CI) | 1.06 (0.41 –2.77) P = .91 | 3.33 (1.03 –10.79) P = .03 | ∞‡ P = .02 | ||||||
* Relative risk of univariate analysis.
† One patient developed bacterial vaginosis.
‡ One cell had zero in the 2 × 2 table for the calculation of relative risk.